skip to content
  1. Home
  2. >
  3. Questions
  4. >
  5. ABCL: Hello Team, ABCL, buy, sell, or hold? [AbCellera Biologics Inc.]
You can view 2 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello Team,

ABCL, buy, sell, or hold?

I would appreciate if you could speak to, cash flow, debt, and growth expectations.

Thanks,
Saeed
Asked by Saeed on December 07, 2023
5i Research Answer:

ABCL is down 52% this year, as sales have dropped off a cliff the last two years. It has $700M cash, but losing money ($132M loss expected this year). In the recent 12 months it did have marginally positive cash flow. Sales are expected to rise 75% next year, but still only to less than $60M. Without it doing an acquisition with its cash, we do not see a big catalyst for recovery here and would be more interested in selling.